Venture Partner
Wellington PartnersCheck size: €2M-€20M initial investments, as published by Wellington Partners.
Dr. Mel Spigelman invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, medical devices, diagnostics and digital health.
Breakthrough science and medical innovation led by experienced teams with clear patient value and international potential.
The firm focuses on life sciences; non-healthcare opportunities and assets without strong scientific or clinical rationale are less aligned.
Show the unmet need, scientific evidence, differentiation, development plan, team and the value-inflection points funded by €2M-€20M.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Dr. Mel Spigelman is a current Venture Partner at Wellington Partners, according to the firm's official roster. No additional background is inferred where the firm does not publish a biography.